Simulations Plus partners with pharma firm on AI drug modeling

🌐 Investing.com (Cyprus) — 2026-10-08

Simulations Plus has reportedly partnered with a pharmaceutical company on AI-based drug modeling. The article provides no further details about the partner or the collaboration.

Deals Health AI & Tech AI drug modeling pharmaceutical research Simulations Plus industry partnership

Read original source →

Palmer signs contract to stay at Chelsea until 2034
Punch Nigeria — 2026-10-10
Democrats explode over Trump’s Russia diesel deal
The Hill — 2026-10-10
How a South African billionaire is turning a corner of Somerset into ‘one man’s estate’
The Guardian — 2026-10-10
Starbucks To Acquire Chipotle? Neither Stock Is A Buy Now
Seeking Alpha — 2026-10-10
SEC DG proposes investment funds to finance university hostels
Nairametrics Nigeria — 2026-10-10
Arsenal to Submit Bid for Liverpool Transfer Target Gilberto Mora
Yahoo Sports — 2026-10-10

Simulations Plus partners with pharma firm on AI drug modeling

AI Summary

Related Articles

Palmer signs contract to stay at Chelsea until 2034

Democrats explode over Trump’s Russia diesel deal

How a South African billionaire is turning a corner of Somerset into ‘one man’s estate’

Starbucks To Acquire Chipotle? Neither Stock Is A Buy Now

SEC DG proposes investment funds to finance university hostels

Arsenal to Submit Bid for Liverpool Transfer Target Gilberto Mora